Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Establish a clinical cohort of acute ischemic stroke patients and find the determinant of the prognosis.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Acute ischemia stroke | Best medcine treatment. It including antiplatelet drugs, statins, hypotensive drugs, antidiabetics, neurotrophic drugs, butylphthalide, edaravone. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| routine therapy of acute ischemia stroke | Other | Routine therapy of acute ischemia stroke based on the guidelines, which generally includes two parts: evaluation and medicine treatment. Evaluation includes peripheral blood test, radiologic examination, electrophysiological examination, ultrasonic examination. Medicine treatment includes drug therapy and rehabilitation. |
| Measure | Description | Time Frame |
|---|---|---|
| Progressively deterioration in acute phase | Number of participants whose SNOB (Standardised nursing observations for stroke) score at 7 days post ischemia stroke ≤ 2 points compared to baseline, and/or NIHSS score at 7 days post ischemia stroke ≥ 2 points compared to baseline are identified as progressively deterioration in acute phase. | 7 days after ischemia stroke onset |
| Bad prognosis of acute ischemia stroke | Number of participants whose mRS (Modified rankin scale) score at 90 days after ischemia > 2 are identified as bad prognosis. | 90 days after ischemia stroke onset |
| Measure | Description | Time Frame |
|---|---|---|
| Recurrent vascular episode | Including transient ischemia attack, intracranial hemorrhage, ischemia stroke | 1 year |
| Recurrent artery stenosis | Degree of artery stenosis at one year after stenting > 50% |
Not provided
Inclusion Criteria:
Age 30-90, no gender restrictions.
Onset of disease ≤7 days.
Meet either of the following two conditions:
① Transient ischemic attack (TIA)
② Ischemia stroke (IS) Note: Acute IS diagnosis criteria: sudden and persistent focal or widespread neurological dysfunction, excluding other non-vascular causes of brain dysfunction (such as brain infection, head injury, brain tumor, epilepsy, severe metabolic diseases, or degenerative neurological diseases), confirmed by image as new IS. TIA diagnosis criteria: sudden and reversible focal neurological or retinal ischemic deficit caused by a reversible ischemia, usually lasting less than 24 hours, with no evidence of new IS on imaging, and excluding other non-ischemic causes (such as brain infection, head injury, brain tumor, epilepsy, severe metabolic diseases, or degenerative neurological diseases).
Signed informed consent
Exclusion Criteria:
Not provided
Who sufferred acute ischemia stroke and be admitted to the ward of Ruijin Hospital, and meets the inclusion criteria, and does not meet the exclusion criteria.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Wei Jin, PhD. MD. | Contact | 18916705082 | jw12170@rjh.com.cn |
| Name | Affiliation | Role |
|---|---|---|
| Wei Jin, PhD. MD. | Ruijin Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ruijin hospital | Recruiting | Shanghai | Shanghai Municipality | 200000 | China |
Results of the research will be shared in the form of paper publishing. Other researchers who wants to know the details can contact with the PI.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000083242 | Ischemic Stroke |
| ID | Term |
|---|---|
| D020521 | Stroke |
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
|
| one year after stenting |
| Unhealthy status | Any dimension in EQ-5D-3L (the generic three-level EuroQol five-dimensional questionnaire) score ≥ 2 | 1 year |
| D009422 |
| Nervous System Diseases |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |